10-Q Filing

TENET HEALTHCARE CORP CIK: 70318 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0000070318-21-000017`
Period End Date	20210331
Filing Date	20210430
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	thc-20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 92 Income Statement 66 Cash Flow Statement 92 Comprehensive Income 18

Balance Sheet 92 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation and amortization	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$6.17B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$6.04B	USD	Point-in-time
Other intangible assets, accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.28B	USD	Point-in-time
Other intangible assets, accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.33B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.45B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.14B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Common stock, authorized shares (in shares)	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.69B	USD	Point-in-time
Common stock, authorized shares (in shares)	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.75B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	154.41M	shares	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$368.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	155.02M	shares	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$368.00M	USD	Point-in-time
Common stock in treasury (in shares)	`TreasuryStockCommonShares`	48.34M	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$139.00M	USD	Point-in-time
Common stock in treasury (in shares)	`TreasuryStockCommonShares`	48.33M	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$140.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.31B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.50B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.15B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.70B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$2.53B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$2.58B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$297.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$325.00M	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($6,172 at March 31, 2021 and $6,043 at December 31, 2020)	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$6.59B	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($6,172 at March 31, 2021 and $6,043 at December 31, 2020)	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$6.69B	USD	Point-in-time
Goodwill	`Goodwill`	$8.80B	USD	Point-in-time
Goodwill	`Goodwill`	$8.81B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($1,331 at March 31, 2021 and $1,284 at December 31, 2020)	`IntangibleAssetsNetExcludingGoodwill`	$1.59B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($1,331 at March 31, 2021 and $1,284 at December 31, 2020)	`IntangibleAssetsNetExcludingGoodwill`	$1.60B	USD	Point-in-time
Total assets	`Assets`	$27.11B	USD	Point-in-time
Total assets	`Assets`	$26.55B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$145.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$137.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10B	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$942.00M	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$907.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$263.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$243.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$248.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$290.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$68.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$70.00M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$917.00M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$659.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.33B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.25B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.85B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.93B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$15.57B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$15.10B	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$735.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$763.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$497.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$478.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$29.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$29.00M	USD	Point-in-time
Contract liabilities long-term	`ContractWithCustomerLiabilityNoncurrent`	$655.00M	USD	Point-in-time
Contract liabilities long-term	`ContractWithCustomerLiabilityNoncurrent`	$918.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.62B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.59B	USD	Point-in-time
Total liabilities	`Liabilities`	$24.22B	USD	Point-in-time
Total liabilities	`Liabilities`	$23.55B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.99B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.95B	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 155,021,894 shares issued at March 31, 2021 and 154,407,524 shares issued at December 31, 2020	`CommonStockValue`	$7.00M	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 155,021,894 shares issued at March 31, 2021 and 154,407,524 shares issued at December 31, 2020	`CommonStockValue`	$8.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.84B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.84B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-282.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-281.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.03B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.13B	USD	Point-in-time
Common stock in treasury, at cost, 48,334,419 shares at March 31, 2021 and 48,337,947 shares at December 31, 2020	`TreasuryStockCommonValue`	$2.41B	USD	Point-in-time
Common stock in treasury, at cost, 48,334,419 shares at March 31, 2021 and 48,337,947 shares at December 31, 2020	`TreasuryStockCommonValue`	$2.41B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$28.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$123.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$893.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$909.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$503.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$437.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$937.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.02B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$26.55B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$27.11B	USD	Point-in-time

Income Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net operating revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.78B	USD	1 Quarter
Net operating revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.52B	USD	1 Quarter
Grant income	`RevenueNotFromContractWithCustomer`	$31.00M	USD	1 Quarter
Grant income	`RevenueNotFromContractWithCustomer`	-	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$28.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$42.00M	USD	1 Quarter
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.19B	USD	1 Quarter
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.20B	USD	1 Quarter
Supplies	`SuppliesExpense`	$804.00M	USD	1 Quarter
Supplies	`SuppliesExpense`	$763.00M	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.01B	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.07B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$203.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$224.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$20.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$55.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-2.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-13.00M	USD	1 Quarter
Net gains on sales, consolidation and deconsolidation of facilities	`NetGainonSaleConsolidationAndDeconsolidationOfFacilities`	-	USD	1 Quarter
Net gains on sales, consolidation and deconsolidation of facilities	`NetGainonSaleConsolidationAndDeconsolidationOfFacilities`	$2.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$520.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$327.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$243.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$240.00M	USD	1 Quarter
Other non-operating income, net	`OtherNonoperatingIncomeExpense`	$10.00M	USD	1 Quarter
Other non-operating income, net	`OtherNonoperatingIncomeExpense`	$1.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-23.00M	USD	1 Quarter
Income from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$85.00M	USD	1 Quarter
Income from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$267.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$45.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-75.00M	USD	1 Quarter
Income from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$222.00M	USD	1 Quarter
Income from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$160.00M	USD	1 Quarter
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	-	USD	1 Quarter
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-1.00M	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Net income	`ProfitLoss`	$159.00M	USD	1 Quarter
Net income	`ProfitLoss`	$222.00M	USD	1 Quarter
Less: Net income available to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$66.00M	USD	1 Quarter
Less: Net income available to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$125.00M	USD	1 Quarter
Net income available to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$97.00M	USD	1 Quarter
Net income available to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$93.00M	USD	1 Quarter
Income from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$94.00M	USD	1 Quarter
Income from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$97.00M	USD	1 Quarter
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.00M	USD	1 Quarter
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Net income available to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$97.00M	USD	1 Quarter
Net income available to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$93.00M	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.91	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.90	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Total earnings (loss) per share, basic (in dollars per share)	`EarningsPerShareBasic`	$0.91	USD	1 Quarter
Total earnings (loss) per share, basic (in dollars per share)	`EarningsPerShareBasic`	$0.89	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.90	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.89	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Total earnings (loss) per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.88	USD	1 Quarter
Total earnings (loss) per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.90	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.31M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	104.35M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.73M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.06M	shares	1 Quarter

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$159.00M	USD	1 Quarter
Net income	`ProfitLoss`	$222.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$203.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$224.00M	USD	1 Quarter
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$24.00M	USD	1 Quarter
Deferred income tax expense (benefit)	`DeferredIncomeTaxExpenseBenefit`	$-79.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$13.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$14.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$20.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$55.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-2.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-13.00M	USD	1 Quarter
Net gains on sales, consolidation and deconsolidation of facilities	`NetGainonSaleConsolidationAndDeconsolidationOfFacilities`	-	USD	1 Quarter
Net gains on sales, consolidation and deconsolidation of facilities	`NetGainonSaleConsolidationAndDeconsolidationOfFacilities`	$2.00M	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-23.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$11.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-28.00M	USD	1 Quarter
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$10.00M	USD	1 Quarter
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$9.00M	USD	1 Quarter
Pre-tax loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.00M	USD	1 Quarter
Pre-tax loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	-	USD	1 Quarter
Other items, net	`OtherNoncashIncomeExpense`	$7.00M	USD	1 Quarter
Other items, net	`OtherNoncashIncomeExpense`	$-2.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$53.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-14.00M	USD	1 Quarter
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$-130.00M	USD	1 Quarter
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$-23.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$-2.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$-19.00M	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-87.00M	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-144.00M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$6.00M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-51.00M	USD	1 Quarter
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$51.00M	USD	1 Quarter
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$68.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$534.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$129.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$121.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$182.00M	USD	1 Quarter
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$55.00M	USD	1 Quarter
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$25.00M	USD	1 Quarter
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$13.00M	USD	1 Quarter
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$11.00M	USD	1 Quarter
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$6.00M	USD	1 Quarter
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$10.00M	USD	1 Quarter
Purchases of marketable securities and equity investments	`PaymentsToAcquireInvestments`	$11.00M	USD	1 Quarter
Purchases of marketable securities and equity investments	`PaymentsToAcquireInvestments`	$4.00M	USD	1 Quarter
Other long-term assets	`PaymentsToAcquireOtherProductiveAssets`	$8.00M	USD	1 Quarter
Other long-term assets	`PaymentsToAcquireOtherProductiveAssets`	$2.00M	USD	1 Quarter
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-18.00M	USD	1 Quarter
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-145.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-204.00M	USD	1 Quarter
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$240.00M	USD	1 Quarter
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	-	USD	1 Quarter
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$740.00M	USD	1 Quarter
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	1 Quarter
Repayments of other borrowings	`RepaymentsOfOtherDebt`	$48.00M	USD	1 Quarter
Repayments of other borrowings	`RepaymentsOfOtherDebt`	$541.00M	USD	1 Quarter
Proceeds from other borrowings	`ProceedsFromOtherDebt`	$7.00M	USD	1 Quarter
Proceeds from other borrowings	`ProceedsFromOtherDebt`	$4.00M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.00M	USD	1 Quarter
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$119.00M	USD	1 Quarter
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$76.00M	USD	1 Quarter
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$6.00M	USD	1 Quarter
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$2.00M	USD	1 Quarter
Purchases of noncontrolling interests	`PaymentsToMinorityShareholders`	$2.00M	USD	1 Quarter
Purchases of noncontrolling interests	`PaymentsToMinorityShareholders`	-	USD	1 Quarter
Proceeds from exercise of stock options and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.00M	USD	1 Quarter
Proceeds from exercise of stock options and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$7.00M	USD	1 Quarter
Medicare advances and grants received by unconsolidated affiliates	`ProceedsFromContributionsFromAffiliates`	$19.00M	USD	1 Quarter
Medicare advances and grants received by unconsolidated affiliates	`ProceedsFromContributionsFromAffiliates`	-	USD	1 Quarter
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$40.00M	USD	1 Quarter
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-68.00M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-694.00M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$426.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-305.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$351.00M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$262.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.14B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$613.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.45B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$262.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.14B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$613.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.45B	USD	Point-in-time
Interest paid, net of capitalized interest	`InterestPaidNet`	$172.00M	USD	1 Quarter
Interest paid, net of capitalized interest	`InterestPaidNet`	$190.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$2.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$3.00M	USD	1 Quarter

Comprehensive Income 18 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$159.00M	USD	1 Quarter
Net income	`ProfitLoss`	$222.00M	USD	1 Quarter
Amortization of net actuarial loss included in other non-operating income, net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$2.00M	USD	1 Quarter
Amortization of net actuarial loss included in other non-operating income, net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$3.00M	USD	1 Quarter
Unrealized gains on debt securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.00M	USD	1 Quarter
Unrealized gains on debt securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	-	USD	1 Quarter
Other comprehensive income before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$3.00M	USD	1 Quarter
Other comprehensive income before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$3.00M	USD	1 Quarter
Income tax expense related to items of other comprehensive income	`OtherComprehensiveIncomeLossTax`	$4.00M	USD	1 Quarter
Income tax expense related to items of other comprehensive income	`OtherComprehensiveIncomeLossTax`	$2.00M	USD	1 Quarter
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$1.00M	USD	1 Quarter
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-1.00M	USD	1 Quarter
Comprehensive net income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$221.00M	USD	1 Quarter
Comprehensive net income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$160.00M	USD	1 Quarter
Less: Comprehensive income available to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$125.00M	USD	1 Quarter
Less: Comprehensive income available to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$66.00M	USD	1 Quarter
Comprehensive income available to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$96.00M	USD	1 Quarter
Comprehensive income available to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$94.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.